Pharmaniaga Berhad's latest marketcap:
As of 07/05/2025, Pharmaniaga Berhad's market capitalization has reached $49.4 M. According to our data, Pharmaniaga Berhad is the 29886th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 49.4 M |
| Revenue (ttm) | 910.11 M |
| Net Income (ttm) | 32.09 M |
| Shares Out | 1.44 B |
| EPS (ttm) | 0.02 |
| Forward PE | 4.14 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/20/2025 |
Pharmaniaga Berhad's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | RM49.4 M | -56.34% | 29886 |
| 12/31/2024 | RM511.64 M | -7.79% | 22432 |
| 12/29/2023 | RM554.87 M | -22.28% | 21866 |
| 12/30/2022 | RM713.93 M | -26.35% | 19269 |
| 12/31/2021 | RM969.37 M | -25.92% | 17974 |
| 12/31/2020 | RM1.31 B | 143.16% | 14103 |
| 12/31/2019 | RM538.13 M | -25.69% | 16745 |
| 12/31/2018 | RM724.2 M | -39.41% | 14574 |
| 12/29/2017 | RM1.2 B | -13.06% | 12958 |
| 12/30/2016 | RM1.37 B | -16.51% | 11126 |
Company Profile
About Pharmaniaga Berhad
Pharmaniaga Berhad is an integrated healthcare service provider operating primarily in Malaysia, Indonesia, and internationally. Established in 1994 and headquartered in Shah Alam, Malaysia, the company functions as an investment holding entity with diversified operations across the healthcare sector.
Business Segments
The company operates through three core segments:
- Logistics and Distribution – Manages the supply chain of pharmaceutical and medical products.
- Manufacturing – Focuses on producing generic drugs, over-the-counter medicines, and food supplements.
- Indonesia – Oversees operations and market expansion in Indonesia.
Key Activities
- Manufacturing, distribution, and marketing of pharmaceutical and medical products.
- Supply, trading, and installation of medical and hospital equipment.
- Research and development of pharmaceutical innovations.
- Distribution and trading of diagnostic products.
- Development of pharmacy management systems for inventory and sales tracking.
Pharmaniaga Berhad plays a vital role in Malaysia's healthcare ecosystem, ensuring accessibility to essential medicines and medical solutions.
Frequently Asked Questions
-
What is Pharmaniaga Berhad's (KLSE-PHARMA) current market cap?As of 07/05/2025, Pharmaniaga Berhad (including the parent company, if applicable) has an estimated market capitalization of $49.4 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Pharmaniaga Berhad (KLSE-PHARMA) rank globally by market cap?Pharmaniaga Berhad global market capitalization ranking is approximately 29886 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.